
Inveox offers a comprehensive, automated pre-analytical system for pathology laboratories, aiming to improve lives by making cancer diagnosis faster, safer, and more reliable. Their "pathos ecosystem" integrates software platforms, reusable products, and hardware modules to digitize, automate, and connect histopathology processes from sample collection to analysis. Key components include the invorder digital processing system for paperless orders, the samplex module for sample pre-processing and status tracking, and intelligent sample containers for safe transport. Additional modules like the Cassette Marking Module (CMM) and Sample Transfer Module (STM) further automate sample preparation. Founded in 2017 by Maria and Dominik Sievert, Inveox has received numerous accolades and is dedicated to reducing errors and improving patient safety in cancer diagnostics.

Inveox offers a comprehensive, automated pre-analytical system for pathology laboratories, aiming to improve lives by making cancer diagnosis faster, safer, and more reliable. Their "pathos ecosystem" integrates software platforms, reusable products, and hardware modules to digitize, automate, and connect histopathology processes from sample collection to analysis. Key components include the invorder digital processing system for paperless orders, the samplex module for sample pre-processing and status tracking, and intelligent sample containers for safe transport. Additional modules like the Cassette Marking Module (CMM) and Sample Transfer Module (STM) further automate sample preparation. Founded in 2017 by Maria and Dominik Sievert, Inveox has received numerous accolades and is dedicated to reducing errors and improving patient safety in cancer diagnostics.
What they do: Automated, digitized histopathology ecosystem (hardware + software) to streamline biopsy-to-diagnosis workflows
Founded: 2017
Founders / leadership: Dominik Sievert and Maria Sievert
Headquarters: Garching bei München (Munich area), Germany
Notable product names: invorder, samplex, Cassette Marking Module (CMM), Sample Transfer Module (STM)
Series A announced 2019-08-06; total reported funding amount: 19,050,000 USD
Pre-analytical automation and digitization for histopathology laboratories to reduce human error and speed cancer diagnostics.
2017
Medtech / Digital pathology
Series A funding round announced on 2019-08-06; overall reported total funding amount is 19,050,000 USD